Ingredion (INGR) Q1 2026 earnings review
Argo Plant Nightmare Crushes Margins and Forces Guidance Cut
Ingredion's Q1 2026 print revealed severe operational vulnerabilities. While consolidated revenue was relatively stable (down 1% YoY), profitability collapsed. A 'thermal event' and prolonged recovery at the critical Argo facility wiped out 63% of the U.S./Canada segment's operating income. Despite management lauding the 8th consecutive quarter of volume growth in the Texture & Healthful Solutions (T&HS) segment, it was not enough to offset the U.S. manufacturing woes and Mexican FX headwinds. Consequently, management slashed its FY26 adjusted EPS guidance from an implied $11.00-$11.80 range down to $10.45-$11.15.
🐂 Bull Case
The Texture & Healthful Solutions segment achieved its 8th consecutive quarter of volume growth, proving resilience in demand for clean label and specialized ingredients.
The 'All Other' segment, driven by the plant-based protein business, turned a $3 million operating profit, reversing losses from previous years and proving the viability of this emerging platform.
🐻 Bear Case
The U.S./Canada segment's operating income dropped 63% YoY ($92M to $34M). Management pushed the 'return to normal operations' timeline to the second half of the year, implying Q2 will remain heavily pressured.
FY26 Adjusted EPS guidance was cut by roughly $0.60 at the midpoint. Adjusted Operating Income is now projected to be flat to down low single-digits for the year, confirming an earnings recession.
⚖️ Verdict: 🔴
Bearish. The magnitude of the Argo facility disruption is alarming, effectively wiping out the profitability of a core segment. Combined with a guidance cut and negative price/mix across multiple segments, the path to near-term earnings recovery looks highly compromised.
Key Themes
Argo Facility Failure Decimates U.S./Canada Profitability
The operational issues at the Argo plant, previously flagged as a stubborn headwind, have evolved into a severe drag. U.S./Canada segment operating income plummeted 63% YoY to just $34 million. The recovery timeline has slipped again, with management now targeting the second half of the year for normal operations. The company expects $20 million in pre-tax direct costs related to a thermal event at this facility in FY26.
Texture & Healthful Solutions Remains the Lone Growth Engine
Stable. T&HS delivered a 2% net sales increase to $617 million. This was driven primarily by strong volume (+ $13M) for the company's clean label solutions portfolio. This marks the 8th consecutive quarter of volume growth for the segment, reinforcing its position as Ingredion's primary strategic pillar amidst core industrial weakness.
Volume Growth in T&HS Comes at the Expense of Pricing
Management touted 'broad-based net sales volume growth' in T&HS due to strong customer demand. However, this narrative obscures a critical data point: price and mix were a negative $11 million headwind in the quarter. Consequently, despite the robust volume narrative, segment operating income barely budged, growing a paltry 1% YoY to $100 million. This indicates limited pricing power and margin compression even in their best segment.
Plant-Based Protein Hits Profitability Inflection
Accelerating. The 'All Other' segment, which houses the plant-based protein business, posted a $3 million operating profit, up from $0 in the prior year. This signals that massive past investments in pea protein ingredients are finally reaching scale and contributing positively to the bottom line.
Macroeconomic Weakness and Mexican FX Drag LATAM
Decelerating. The Food & Industrial Ingredients LATAM segment saw operating income decline 9% YoY to $115 million. Management explicitly cited Mexican transactional currency headwinds and softer volumes tied to an 'increasingly uncertain macroeconomic environment.' The strong Mexican peso is punishing local manufacturing costs and weighing heavily on regional margins.
Other KPIs
Decelerating sharply from 15.1% in 25Q1. This 330-basis-point margin compression was driven almost entirely by the unabsorbed fixed costs and inefficiencies tied to the Argo facility outage, combined with broad inability to pass through manufacturing inflation via pricing.
Down slightly from $1.03 billion at the end of FY25. The company generated $33 million in operating cash flow in Q1, down from $77 million in the prior year, driven by a $205 million drag from working capital changes. Total debt remains flat at $1.8 billion.
Guidance
Decelerating. This is a severe downgrade from the previously guided range of $11.00-$11.80 provided in 25Q4. It highlights that the Argo facility issues and LATAM macro headwinds are significantly worse than anticipated just three months ago.
Decelerating. This confirms that the Q1 collapse is not a quick fix. Management previously guided this segment to be 'flat' for FY26. The new guide reflects a massive downward revision directly tied to the Argo plant's extended recovery timeline.
Decelerating. Lapping a record 25Q2 ($273 million), the upcoming quarter faces extremely tough comparables alongside ongoing Argo inefficiencies, ensuring at least one more quarter of significant profit contraction.
Decelerating from previous expectations. Management had previously guided this segment to grow 'low to mid-single digits' for 2026. The slight step-down indicates that input cost inflation and negative price/mix are tempering the profit upside of their volume growth.
Key Questions
Argo Facility Concrete Timeline
You shifted the Argo 'return to normal' target from Q1 to the second half of the year. What specific mechanical or supply chain milestones remain to be cleared, and what is the maximum downside risk to U.S./Canada margins if this slips into Q4?
T&HS Pricing Power
T&HS posted 8 consecutive quarters of volume growth, yet price/mix was a negative $11 million headwind this quarter, resulting in only 1% OpInc growth. Is this a structural shift in the competitive landscape for clean-label ingredients, or purely a pass-through of lower input costs?
LATAM FX Mitigation
With the Mexican peso acting as a sustained transactional headwind, what structural changes or pricing actions are being implemented in LATAM to defend the 20%+ margins we saw in previous years?
Working Capital Drag
Operating cash flow fell to $33 million, heavily impacted by a $205 million outflow from working capital changes. Is this related to inventory build-ups buffering the Argo disruption, or are there underlying receivables collection issues?